| Literature DB >> 30483353 |
Gek Phin Chua1, Hiang Khoon Tan1, Mihir Gandhi2.
Abstract
The goal of this study is to determine the type of information cancer patients need and to measure the extent to which these information needs are met by measuring patients' levels of satisfaction. A self-administered questionnaire developed through extensive literature reviews was pilot tested on 11 cancer patients using convenience sampling in a large ambulatory cancer centre in Singapore. All eligible patients attending the centre during a 5-month period were invited to complete the 76-item survey that had been designed to evaluate self-reported information needs and level of satisfaction with the information received while undergoing cancer treatment. The importance of information and the level of satisfaction with needs being met were assessed with the 5-point Likert scale. A total of 411 patients (50%) completed the survey. Almost all patients wanted information about the disease, tests and investigations, treatment, side-effects, sexuality, psychosocial support and financial matters, and most items listed in the questions in each selection were rated as important or very important. Responses indicate that patients were generally satisfied with the information provided especially on diagnosis and diagnostic tests, treatment and overall experience but there are information needs that need to be addressed more efficiently and effectively. The findings of this study support previous research which indicates that cancer patients who are receiving treatment have many information needs. Respondents were generally satisfied with the information provided, although some discrepancies were noted which reflect the complexities associated with cancer patient education.Entities:
Keywords: cancer; communication; importance of information; patient information needs; satisfaction; sexuality; supportive care background
Year: 2018 PMID: 30483353 PMCID: PMC6214674 DOI: 10.3332/ecancer.2018.873
Source DB: PubMed Journal: Ecancermedicalscience ISSN: 1754-6605
Characteristics of survey respondents.
| Characteristics, | ||
|---|---|---|
| Sex | ||
| Male | 153 (37.8) | |
| Female | 259 (64.0) | |
| Age (years) | ||
| 21–40 | 45 (10.9) | |
| 41– 60 | 223 (54.3) | |
| 60 and above | 142 (34.5) | |
| Unknown | 1 | |
| Ethnicity | ||
| Chinese | 317 (77.1) | |
| Malay | 46 (11.2) | |
| Indian | 20 (4.9) | |
| Others | 27 (6.6) | |
| Unknown | 1 | |
| Marital status | ||
| Married | 320 (77.9) | |
| Non Married | 85 (20.7) | |
| Unknown | 6 | |
| Highest level of education | ||
| Primary or less | 81 (19.7) | |
| Secondary/higher secondary | 213 (51.8) | |
| Tertiary | 109 (26.5) | |
| Unknown | 8 (2) | |
| Type of treatment ( | ||
| Surgery | 248 (60.3) | |
| Radiation therapy | 118 (28.7) | |
| Chemotherapy | 404 (98.3) | |
| Hormonal therapy | 45 (10.9) | |
| Clinical trials | 62 (15.1) | |
| Employment status | ||
| Employed | 176 (42.8) | |
| Unemployed | 230 (56.0) | |
| Unknown | 5 | |
| Cancer type | ||
| Breast | 115 (28.0) | |
| Colon/rectal | 60 (14.6) | |
| Lung | 52 (12.6) | |
| Others | 171 (41.6) | |
| Unknown | 39 | |
| Disease status | ||
| Newly diagnosed | 304 (74.0) | |
| Recurrent | 98 (23.8) | |
| Unknown | 9 | |
| Treatment modality | ||
| One | 93 (23.0) | |
| Two or more | 318 (78.5) | |
Importance and satisfaction level of respondents relating to information received about various aspects of care.
| Aspects of care | Importance level | Satisfaction level | Satisfaction level weighted by importance level of item of care |
|---|---|---|---|
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |
| Diagnosis ( | 4.39 (4.31, 4.46) | 3.93 (3.86, 3.99) | 3.94 (3.88, 5.01) |
| Being informed about which type of cancer you have | 4.50 (4.42, 4.58) | 4.11 (4.03, 4.19) | |
| Being informed about the causes of the type of cancer you have | 4.30 (4.21, 3.39) | 3.71 (3.62, 3.79) | |
| Being informed about the variety of treatment options available in terms of managing your cancer | 4.48 (4.40, 4.56) | 4.08 (4.01, 4.15) | |
| Being informed about the survival rates for your cancer | 4.27 (4.17, 4.37) | 3.82 (3.73, 3.90) | |
| Tests and investigations ( | 4.48 (4.41, 4.55) | 4.07 (4.01, 4.14) | 4.08 (4.01, 4.14) |
| Being informed about the purpose of the tests (e.g., computed tomography scans, magnetic resonance imaging scans and blood tests) | 4.46 (4.39, 4.54) | 4.11 (4.04, 4.18) | |
| Being informed about when you can expect the results | 4.42 (4.34, 4.49) | 4.03 (4.95, 4.10) | |
| Being explained about the results of the tests | 4.56 (4.50, 4.63) | 4.09 (4.01, 4.16) | |
| Surgery ( | 4.49 (4.40, 4.58) | 4.05 (3.96, 4.14) | 4.06 (3.97, 4.14) |
| Being informed about the possible benefits or harms of your cancer surgery (including its success rate) | 4.53 (4.44, 4.62) | 4.11 (4.01, 4.21) | |
| Being informed before the operation for how you would feel afterwards | 4.50 (4.41, 4.60) | 4.07 (3.97, 4.17) | |
| Being informed about the time period of recovery and how you can be an active participant in your treatment | 4.48 | 3.99 | |
| Being informed about the possible late effects of surgery | 4.44 | 3.92 | |
| Being informed on how to care for yourself physically post-surgery | 4.45 | 4.07 | |
| Being informed about what you should or should not do after you leave the hospital/centre | 4.48 | 4.08 | |
| Being informed about who to contact if you are worried about your condition or treatment after you leave the hospital/centre | 4.54 | 4.12 | |
| Radiation therapy ( | 4.35 | 4.04 | 4.04 |
| Being informed about the possible benefits and harm of radiation therapy (including its success rate) | 4.33 | 4.07 | |
| Being equipped with enough information for decision-making about whether you should receive radiation therapy | 4.34 | 4.02 | |
| Being informed about the potential side effects caused by radiation therapy and how to cope with them | 4.40 | 4.04 | |
| Being informed about the duration of the entire radiation therapy and how you can be an active participant in your treatment | 4.36 | 4.15 | |
| Being informed about the possible late effects of radiation therapy | 4.34 | 3.93 | |
| Being informed about who to contact regarding any problems you may have after you leave the centre | 4.35 | 4.00 | |
| Chemotherapy ( | 4.51 | 4.11 | 4.11 |
| Being informed about the possible benefits and harm of chemotherapy (including its success rate) | 4.52 | 4.10 | |
| Being equipped with enough information for decision-making about whether you should receive chemotherapy | 4.51 | 4.10 | |
| Being informed about the potential side effects caused by chemotherapy and how to cope with them | 4.57 | 4.18 | |
| Being informed about the duration of the entire chemotherapy treatment and how you can be an active participant in your treatment | 4.50 | 4.14 | |
| Being informed about the possible late effects of chemotherapy | 4.45 | 3.95 | |
| Being informed about who to contact regarding any problems you may have after you leave the centre | 4.53 | 4.17 | |
| Hormonal therapy ( | 4.49 | 4.16 | 4.17 |
| Being informed about the possible benefits and harm of hormonal (including its success rate) | 4.46 | 4.09 | |
| Being equipped with enough information for decision-making about whether you should receive hormonal therapy | 4.50 | 4.16 | |
| Being informed about the potential side effects caused by hormonal therapy and how to cope with them | 4.50 | 4.21 | |
| Being informed about the duration of the entire hormonal therapy treatment and how you can be an active participant in your treatment | 4.48 | 4.18 | |
| Being informed about the possible late effects of hormonal therapy | 4.46 | 3.96 | |
| Being informed about who to contact regarding any problems you may have after you leave the centre | 4.55 | 4.34 | |
| Clinical Trials ( | 4.49 | 4.09 | 4.09 |
| Being informed about the eligibility for clinical trials | 4.42 | 4.07 | |
| Being informed about the potential risks and benefits of this treatment | 4.53 | 4.15 | |
| Being informed about your rights as trial participants | 4.48 | 4.10 | |
| Being informed about the differences between standard treatment and this treatment | 4.50 | 3.98 | |
| Being informed about the process and procedures of clinical trial | 4.47 | 4.05 | |
| Being informed about the duration of the entire trial and how you can be an active participant in your treatment | 4.50 | 3.98 | |
| Being informed about whether you could quit halfway after you participated | 4.50 | 4.20 | |
| Being informed about who to contact regarding any problems you may have after you leave the centre | 4.55 | 4.15 | |
| Sexual aspect of care ( | 2.99 | 3.29 | 3.30 |
| Being informed about the effects of cancer treatment on your sexuality or fertility | 3.20 | 3.37 | |
| Being informed about whether having sex during treatment can be harmful to you or your partner | 3.08 | 3.27 | |
| Being informed about when you could or could not have sex | 3.03 | 3.26 | |
| Being informed about the options that can help in your fertility (e.g., sperms banking and embryo storage) | 2.85 | 3.28 | |
| Being informed when you can start a family or have children after the cancer treatment | 2.80 | 3.26 | |
| Psychosocial aspect of care ( | 3.88 | 3.53 | 3.54 |
| Being informed about the psychological and social problems caused by the types of cancer you have and its treatment | 3.84 | 3.44 | |
| Being informed about the services at NCCS for dealing with psychological and social problems caused by cancer you have and its treatment | 3.89 | 3.47 | |
| Being informed that the cancer is not contagious | 3.92 | 3.70 | |
| Supportive care ( | 4.10 | 3.33 | 3.36 |
| Being informed about the types of food/supplement that are good for you | 4.46 | 3.53 | |
| Being informed about things you can do to help yourself get well | 4.42 | 3.56 | |
| Being informed about complementary therapies (e.g., traditional Chinese medicine and art therapy) | 3.98 | 3.21 | |
| Being informed about supporting resources available (e.g., support group and counsellors) | 3.94 | 3.33 | |
| Being informed about the patient education services and classes | 3.78 | 3.17 | |
| Being informed about cancer survivor support services (e.g., counselling, screening and follow-up care for survivors) | 4.07 | 3.28 | |
| Being informed about the multi-disciplinary care clinics where your entire care team discusses your case | 4.06 | 3.22 | |
| Financial care ( | 4.44 | 3.64 | 3.64 |
| Being informed about the costs of your treatment(s) | 4.49 | 3.72 | |
| Being informed about the coverage by benefits/extended medical insurance | 4.42 | 3.59 | |
| Being informed about Medisave, Medishield and Medifund and how they apply to your situation | 4.46 | 3.68 | |
| Being informed on how to access financial support or advice | 4.40 | 3.55 | |
| Overall experience ( | 4.41 | 4.03 | 4.04 |
| Receiving information from NCCS professionals, throughout your experience as a cancer patient | 4.43 | 3.97 | |
| Having the opportunity for your family or yourself to talk to a doctor | 4.51 | 4.14 | |
| Receiving a sufficient amount of information to help you make a decision or cope with the disease and treatment | 4.48 | 3.99 | |
| Receiving information that was easy to understand | 4.49 | 4.07 | |
| Receiving information at the time when you need it | 4.45 | 3.97 | |
| Receiving information in the language you understand | 4.48 | 4.17 | |
| Receiving information that was sufficiently sensitive to and respectful of your culture? | 4.08 | 3.99 | |
| Having questions answered honestly | 4.50 | 4.11 | |
| Having enough time to ask the doctor/nurse or healthcare professionals questions | 4.51 | 4.09 | |
| Having a variety of information sources (e.g., leaflet and audio materials) | 4.13 | 3.79 |
CI: Confidence interval; NCCS: National Cancer Centre Singapore
Bold values represent the mean values less than 4.0 with P-value < 0.05 for comparison with 4.0 using the one-sample t-test.
Figure 1.Importance and satisfaction level of respondents relating to information received overall and about various aspects of care.